Pilianidis, G.; Papanastasiou, G.; Tikoudi, P.; Themistocleous, A.; Farmakis, G.; Dolianitis, K. Can Euglycemic Diabetic Ketoacidosis Caused by SGLT2 Inhibitors Be Avoided in COVID-19 and Other Acute Infections? EJCRIM 2024, 11 (3). https://doi.org/10.12890/2024_004282.